18F-Fluciclovine Versus 68Ga-PSMA-11 Imaging for Prostate Cancer Biochemical Recurrence

home / peers-and-perspectives / 18f-fluciclovine-versus-68ga-psma-11-imaging-for-prostate-cancer-biochemical-recurrence

Steven Finkelstein, MD, DABR, FACRO, and Louis J. Mazzarelli, MD, react to the article, “A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT,” by Pernthaler B, et al.

© 2024 MJH Life Sciences

All rights reserved.